MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-CH-01-0006789
Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.36 Cr
▲ 48% YoY
Net profit · FY 2025
₹9.05 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹76.72 Lakh
EBITDA margin 7.4%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹8 Cr
Issued & subscribed
Open charges
₹10.3 Cr
Satisfied ₹8.97 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
11
Provident fund records
About Oasis Pharma and Phytomolecules Private Limited
Data last updated:
Oasis Pharma and Phytomolecules Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100CH2007PTC045485. Its GSTIN is 02AAACO9325R1Z3 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹8 Cr. It is led by directors Sanjay Dhir (Managing Director) and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 194 – 195. 3rd Floor, Industrial Area Phase – II, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.36 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹9.05 Lakh (net margin 0.9%) and EBITDA of ₹76.72 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 440% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.3 Cr and satisfied charges of ₹8.97 Cr on record. Court records list 12 cases involving the company, including 3 filed by the company and 9 filed against it; 2 cases are pending. The company has 12 deals on record (6 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹5.42 Cr; the latest was in April 2019. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Gujarat Liqui Pharmacaps Private Limited with revenue of ₹10.41 Cr.
Oasis Pharma and Phytomolecules Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-CH-01-0006789). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100CH2007PTC045485
Registration Number 045485
Incorporation Date 08 May 2007
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-CH-01-0006789
CIN history
Oasis Pharma and Phytomolecules has one previous CIN (Corporate Identification Number): U24100DL2007PTC163076. The current CIN is U24100CH2007PTC045485, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100CH2007PTC045485 | Current |
| U24100DL2007PTC163076 | Previous |
Recognitions & Rankings of Oasis Pharma and Phytomolecules
Contact details
Oasis Pharma and Phytomolecules Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot 194 – 195. 3rd Floor, Industrial Area Phase – II, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Comprehensive company report
Oasis Pharma and Phytomolecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Oasis Pharma and Phytomolecules is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Financials of Oasis Pharma and Phytomolecules Private Limited
FY 2025 filings availableOasis Pharma and Phytomolecules Private Limited reported revenue of ₹10.36 Cr (up 48% YoY) for FY 2025.
Revenue · FY 2025
₹10.36 Cr ▲ 48%
Net profit · FY 2025
₹9.05 Lakh margin 0.9%
EBITDA · FY 2025
₹76.72 Lakh margin 7.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 48%
5 years · compounded
▲ 440%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 128%
5 years · compounded
▲ 63%
Revenue has grown at a compounded annual rate (CAGR) of 440% over five years, including 48% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Board of directors of Oasis Pharma and Phytomolecules Private Limited
Oasis Pharma and Phytomolecules has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Dhir | Managing Director | 15 Jan 2015 | 11 Years 9 Months | Current |
| Sanjeev Kumar Also directs: Zenlabs Ethica Limited, Preet Remedies Limited, Ultra Chiron Healthcare Private Limited and 3 more | Director | 12 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Oasis Pharma and Phytomolecules Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gujarat Liqui Pharmacaps Private Limited | ₹10.41 Cr (FY 2025) | -27.0% | Vadodara, Gujarat, India | |||
| Stature Life Sciences Private Limited | ₹10.4 Cr (FY 2025) | 22.0% | Chennai, Tamil Nadu, India | |||
| Oasis Pharma and Phytomolecules Private Limitedthis company | ₹10.36 Cr (FY 2025) | ₹9.05 Lakh | 0.9% | 48.0% | 11 | Chandigarh, India |
| Essenzaa Nutrition Private Limited | ₹10.33 Cr (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Banson Pharmaceuticals Private Limited | ₹10.3 Cr (FY 2024) | 92.0% | Punjab, India |
To see the full peer comparison of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Auditor
Oasis Pharma and Phytomolecules Private Limited is audited by RAVINDER K SHARMA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVINDER K SHARMA & CO | FY 2021 | 016099N |
Shareholding
The shareholding of Oasis Pharma and Phytomolecules Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.3 Cr
Satisfied charges
₹8.97 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2022 | 100591694 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 01 Jan 2014 | 10472289 | Deputy Director of Industries | ₹30 Lakh | Open | |
| 30 Nov 2016 | 100064233 | Hdfc Bank Limited | ₹4.17 Cr | Satisfied | |
| 29 Nov 2009 | 10188476 | Uco Bank | ₹4.8 Cr | Satisfied |
To see the full charge records of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Oasis Pharma and Phytomolecules Private Limited has 12 deals on record (6 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹5.42 Cr; the latest was in April 2019.
Total deals
12
Funding rounds
6
Secondary share transfers
4
Rights issues
2
Disclosed funding
₹5.42 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2019 | Rights issue | ₹50.6 Lakh | Investors: Quixotic Healthcare Limited and Sanjeev Kumar and Satish Kumar and Harpreet Singh and Himjyoti Dhir, Preet Remedies Limited |
| Feb 2015 | Rights issue | ₹73.6 Lakh | Investors: Preet Remedies Limited |
| Dec 2014 | Secondary share transfer | Undisclosed | Buyer: Preet Remedies Limited Seller: an individual |
| Feb 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Fresh Look Aluminium and Steel Private Limited , Agp Bio Mass Products Private Limited , 2 individuals |
| Feb 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Canny Consultants Private Limited , Dhanshree Softech Private Limited , Kakani Enterprises Private Limited |
To see the full deal history of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Oasis Pharma and Phytomolecules Private Limited has 12 court cases on record: 3 filed by Oasis Pharma and Phytomolecules, 9 filed against it. 2 cases are pending and 10 are disposed.
Total cases
12
Filed by the company
3
Filed against the company
9
Pending
2
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 9 | 2 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by an individual | Pending |
| District court, East, Delhi | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
| District court, East, Delhi | Court case (T. P. Civil) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against an individual | Disposed |
| District court, East, Delhi | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oasis Pharma and Phytomolecules Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Oasis Pharma and Phytomolecules Private Limited has a workforce of 11 employees on its EPFO records as of Apr 06, 2024, across 2 active EPFO establishments.
Employee count
11
Active EPFO establishments
2
Employee growth
-47.62%
GST
Oasis Pharma and Phytomolecules has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACO9325R1Z3 | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oasis Pharma and Phytomolecules Private Limited, buy the company report.
Recent activity
Oasis Pharma and Phytomolecules Private Limited has 14 board changes on record since 2013: 2 appointments and 12 cessations. The latest: Satish Kumar ceased to be Director on 30 Jun 2020.
AGM
Oasis Pharma And Phytomolecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Oasis Pharma And Phytomolecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 30 Jun 2022 with Charge ID 100591694 was modified on 23 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100591694 was registered on 30 Jun 2022.
Charges
A charge registered on 30 Nov 2016 via Charge ID 100064233 with Hdfc Bank Limited was fully satisfied on 05 Aug 2021.
Ceased
Satish Kumar ceased to be Director.
Ceased
Swapan Chakraborty ceased to be Director.
Ceased
Rajiv Sharma ceased to be Additional Director.
Ceased
Kamlesh Kumar Mishra ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 4.17 Cr registered on 30 Nov 2016 with Charge ID 100064233 was modified on 28 Mar 2017.
Charges
A charge registered on 29 Nov 2009 via Charge ID 10188476 with Uco Bank was fully satisfied on 13 Feb 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.17 Cr with Charge ID 100064233 was registered on 30 Nov 2016.
14 earlier events are in the company report.
Frequently asked questions
Oasis Pharma and Phytomolecules is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 May 2007 (19+ years old) and is registered under CIN U24100CH2007PTC045485.
Oasis Pharma and Phytomolecules has 2 current directors:
- Sanjay Dhir - Managing Director
- Sanjeev Kumar - Director
The latest financial statements of Oasis Pharma and Phytomolecules on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Oasis Pharma and Phytomolecules is 02AAACO9325R1Z3, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Oasis Pharma and Phytomolecules is U24100CH2007PTC045485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oasis Pharma and Phytomolecules has 12 court cases on record: 3 filed by the company and 9 filed against it. 2 are pending. Most are in the district courts.
Oasis Pharma and Phytomolecules was incorporated on 08 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
Oasis Pharma and Phytomolecules has 12 deals on record (6 funding rounds, 4 secondary share transfers, 2 rights issues), with disclosed funding of ₹5.42 Cr; the latest was in April 2019.
The peers of Oasis Pharma and Phytomolecules by revenue are Gujarat Liqui Pharmacaps Private Limited, Stature Life Sciences Private Limited, Essenzaa Nutrition Private Limited, Banson Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satish Kumar ceased to be Director on 30 Jun 2020. Swapan Chakraborty ceased to be Director on 14 Mar 2020. Rajiv Sharma ceased to be Additional Director on 28 Sep 2017. Oasis Pharma and Phytomolecules has 14 board changes on record in total.
Yes, Oasis Pharma and Phytomolecules is registered as an MSME under Udyam registration (number: UDYAM-CH-01-0006789).